Dynamic HER2-low status among patients with triple negative breast cancer (TNBC): The impact of repeat biopsies

被引：0
|
作者：
Bar, Yael
Dedeoglu, Aylin S.
Fell, Geoffrey G.
Moffett, Natalie J.
Boyraz, Baris
Ly, Amy
Bardia, Aditya
Moy, Beverly
Ellisen, Leif W.
Isakoff, Steven J.
机构：
[1] Massachusetts Gen Hosp, Boston, MA USA
[2] Dana Farber Canc Inst, Boston, MA USA
[3] Massachusetts Gen Hosp Canc Ctr, Boston, MA USA
[4] Harvard Med Sch, Massachusetts Gen Hosp Canc Ctr, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1005
引用
收藏
页数：1
相关论文
共 50 条
  • [21] HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer
    de Moura Leite, Luciana
    Cesca, Marcelle Goldner
    Tavares, Monique Celeste
    Santana, Debora Maciel
    Saldanha, Erick Figueiredo
    Guimaraes, Paula Tavares
    Sa, Daniella Dias Silva
    Simoes, Maria Fernanda Evangelista
    Viana, Rafael Lima
    Rocha, Francisca Giselle
    Loose, Simone Klog
    Silva, Sinara Figueiredo
    Pirolli, Rafaela
    Fogassa, Camilla Albina Zanco
    Mattos, Bruna Raphaeli Silva
    Campos, Fernando Augusto Batista
    Sanches, Solange Moraes
    de Lima, Vladmir Claudio Cordeiro
    Ponde, Noam Falbel
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 190 (01) : 155 - 163
  • [22] HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer
    Luciana de Moura Leite
    Marcelle Goldner Cesca
    Monique Celeste Tavares
    Debora Maciel Santana
    Erick Figueiredo Saldanha
    Paula Tavares Guimarães
    Daniella Dias Silva Sá
    Maria Fernanda Evangelista Simões
    Rafael Lima Viana
    Francisca Giselle Rocha
    Simone Klog Loose
    Sinara Figueiredo Silva
    Rafaela Pirolli
    Camilla Albina Zanco Fogassa
    Bruna Raphaeli Silva Mattos
    Fernando Augusto Batista Campos
    Solange Moraes Sanches
    Vladmir Cláudio Cordeiro de Lima
    Noam Falbel Pondé
    Breast Cancer Research and Treatment, 2021, 190 : 155 - 163
  • [23] Prognostic impact of HER2-low expression in HER2-negative breast cancer under different hormone receptor status
    Bin Xu
    Jianguo Shen
    Jun Shen
    Linbo Wang
    International Journal of Clinical Oncology, 2023, 28 : 543 - 549
  • [24] HER2-Low Status Was Associated With Better Breast Cancer-Specific Survival in Early-Stage Triple-Negative Breast Cancer
    Ma, Youzhao
    Jiao, Dechuang
    Zhang, Jingyang
    Lv, Minhao
    Chen, Xiuchun
    Liu, Zhenzhen
    ONCOLOGIST, 2024, 29 (03): : E309 - E318
  • [25] Her2-low/ HRR proficient early triple negative breast cancer is characterized by good prognosis
    Pellegrino, B.
    Tornali, C.
    Lazzarin, A.
    Cotelli, B.
    Ingallinella, A.
    Campanini, N.
    Tommasi, C.
    Coriano, M.
    Serra, O.
    Michiara, M.
    Boggiani, D.
    Schirone, A.
    Casarini, C.
    Cretella, E.
    Zoppoli, G.
    Lambertini, M.
    Botosso, M.
    Cortesi, L.
    Silini, E. M.
    Musolino, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S328 - S329
  • [26] IMPACT OF HORMONE RECEPTOR STATUS AND HER2 ON SURVIVAL OF TRIPLE NEGATIVE BREAST CANCER PATIENTS
    Xiao, H.
    Tan, F.
    Huang, Y.
    Feldman, J.
    Koniaris, L.
    Gummadi, S.
    Adunlin, G. B.
    Ali, A. A.
    VALUE IN HEALTH, 2013, 16 (03) : A131 - A131
  • [27] Frequency and prognosis of HER2-low status in Mexican patients with metastatic breast cancer
    Martinez-Cannon, Bertha Alejandra
    Verduzco-Aguirre, Haydee Cristina
    CANCER RESEARCH, 2023, 83 (05)
  • [28] Impact of HER2-Low Status on Pathologic Complete Response and Survival Outcome Among Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
    Lee, Young Joo
    Yoo, Tae-Kyung
    Lee, Sae Byul
    Chung, Il Yong
    Kim, Hee Jeong
    Ko, Beom Seok
    Lee, Jong Won
    Son, Byung Ho
    Ahn, Sei Hyun
    Jeong, Hyehyun
    Jung, Jae Ho
    Ahn, Jin-Hee
    Jung, Kyung Hae
    Kim, Sung-Bae
    Lee, Hee Jin
    Gong, Gyungyub
    Kim, Jisun
    JOURNAL OF BREAST CANCER, 2025, 28 (01) : 11 - 22
  • [29] Efficacy and prognosis of HER2-Low and HER2-Zero in triple-negative breast cancer after neoadjuvant chemotherapy
    Shi, Zhendong
    Liu, Yingxue
    Fang, Xuan
    Liu, Xu
    Meng, Jie
    Zhang, Jin
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [30] The Dynamic of HER2-low Expression during Breast Cancer Progression
    Anderson, Sarah
    Bartow, Brooke
    Huang, Xiao
    Wei, Shi
    LABORATORY INVESTIGATION, 2023, 103 (03) : S89 - S89
12345